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Corticosteroids in Experimental Fat Embolization 
WILMONT R. KREIS, M.D.,* S. MARTIN LINDENAUER, M.D.,? 
AND THOMAS L. DENT, M.D.3 
FAT EMBOLI WERE FIRST described 
by Zenker in 1862 [24]. Since that time all 
aspects of the phenomenon have been the 
subject of controversy. Fat embolization 
refers to the finding of fat particles in tis- 
sues (especially lung, kidney, and brain). 
The fat emboli syndrome is a clinical pic- 
ture thought to be produced by severe fat 
embolization. Fat embolization is associ- 
ated with a diverse variety of clinical prob- 
lems but most commonly occurs with 
trauma, associated with fracture of the long 
bones. 
Fat emboli are a common finding at 
autopsy following trauma. Sevitt reports an 
incidence of 89% [19]. However, the inci- 
dence of the fat emboli syndrome is much 
less. The exact incidence in significant 
trauma is difficult to ascertain due to diffi- 
culties in making the diagnosis and a lack 
of precise criteria as to what constitutes 
significant trauma. 
Fat embolization has been implicated as 
the cause of death in individuals dying 
after trauma in 5-25s of cases [ 18, 241. 
Mortality is related to the severity of in- 
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jury and the number of fat emboli per unit 
area of tissue examined at autopsy [7, 191. 
The fat emboli syndrome is most common 
in young males paralleling the incidence of 
severe trauma in this group [ 151. Recently, 
investigators have proposed the use of 
corticosteroids as an adjunct to ventilatory 
assistance and other supportive measures 
in the treatment of pulmonary fat embol- 
ization [3, 9, 211. This study was under- 
taken to evaluate the effects of corticoste- 
roids in an experimental model of fat 
embolization. 
METHODS AND MATERIALS 
Sixteen mongrel dogs were anesthetized 
with intravenous sodium pentobarbital (30 
mg/kg) and maintained with 4 mg/kg/hr 
by continuous intravenous infusion. Ani- 
mals were intubated and maintained on 20 
cc/kg of room air at 16 respirations per 
minute on a fixed volume respirator. 
Catheters were placed in the femoral artery 
and vein for pressure measurements and 
blood sampling. A Swan-Ganz flow directed 
catheter was passed into the pulmonary 
artery from the femoral vein for pressure 
measurements [20]. The animals were 
divided into four groups (Table 1). Four- 
teen animals received Oleic acid USP 0.07 
ml/kg intravenously at time zero. Seven of 
these animals (group 2) simultaneously re- 
ceived methylprednisolone 3 mg/kg intra- 
venously. The other seven animals received 
an equivalent volume of normal saline 
(group 1). One animal received saline only 
(group 3)) and one received only methyl- 
prednisolone (group 4) . 
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Table 1. Experimental and Control Groups 
Number 
Group of dogs Insult Treatment 
1 7 Oleic Acid Saline 
2 7 Oleic Acid Methylprednisolone 
3 1 Saline Saline 
4 1 Saline Methylprednisolone 
Table 2. Mean Arterial pH Determinations in Experimental Fat Embolization 
Time (hours) 
Group 0 ?i 1 2 3 4 
1 7.46(.04) 7.44(.02) 7.40(.03) 7.43(.03) 7.46(.03) 7.44(.02) 
2 7.44(.05) 7.45(.06) 7.45(.06) 7.45(.06) 7.45(.04) 7.45( 03) 
3 7.45 7.45 7.45 7.44 7.44 7.44 
4 7.45 7.44 7.44 7.44 7.44 7.44 






















* Millimeters of mercury. 
Table 4. Mean Pulmonary Artery Pressure in Experimental Fat Embolization* 
Time (hours) 
Group 0 $5 1 2 3 4 
1 20(O) 18(l) 18(l) 20(l) 220) 22(l) 
2 20(O) 3x0) 2ow 20(3) 24(4 21(4) 
3 20 20 1P 18 24 22 
4 20 20 20 24 24 22 
* Centimeters of water. 
Table 5. Mean Pulse Rate in Experimental Fat Bmbolization 
Time (hours) 
Group 0 35 1 2 3 4 
1 167(10) 152(11) 144(12) 165(10) 170(10) 174(10) 
2 160(11) 145(13) 148(8) 150(8) 149(10) 144(8) 
3 170 170 160 160 160 160 
4 175 175 170 170 160 160 
Pulse and arterial pressure were were collected before injection and I$!& 1, 
measured and recorded with a Sanborn 2, 3, and 4 hr after injection and determina- 
transducer and recorder. Pulmonary artery tions of PaO?, pH, and PCO, obtained with 
pressure (PAP) was monitored with a a Radiometer blood gas analyzer. Chest 
water manometer. Arterial blood samples roentgenagrams were obtained befxc inje:- 
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Table 6. Mean Systemic Arterial Pressure in Experimental Fat Embolization* 
Time (hours) 
Group 0 56 1 2 3 
1 130(4) 120(7) 120(5) 130(2) 130(3) 
2 135(10) 125(4) 126(6) 129(6) 131(3) 
3 120 120 120 120 120 
4 125 120 125 125 120 






Table 7. Mean Arterial Pa02 in Experimental Fat Embolization* 
Time (hours) 
Group 0 $4 1 2 3 
1 89(4 64(25) 52(15) 52(8) 49(10) 
2 W(4) 80(15) 71(15) 71(13) 74(10) 
3 87 87 87 86 89 
4 86 89 88 90 88 






Table 8. Graph of Mean Pa02 (f Standard Deviation) in Steroid Treated and Control Dogs Receiving 
Intravenous Oleic Acid 






Fig. 1. Chrst roentgenogram of untreated animal (group 1). Kate diffuse patchy infill :rates. 
Pig. 2. Chest 
aPPe !arance. 
roentgenogram of steroid treated animal (group 2). Note relatively nc X-ma1 
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I Jung fl rom untreated animal (group 1). There is marked congest ion with focal 
hemorrhage. 
tion and 3 hr later. Animals were sacrificed 
at 4 hr and sections of lung, brain, and kid- 
ney were subjected to gross and histologic 
examinations. 
RESULTS 
The arterial blood gas values, pulse, sys- 
temic arterial pressure and pulmonary 
artery pressures (PAP) are summarized in 
Tables 2-7. pH, PCO,, PAP, pulse, and 
arterial pressure were stable in all groups. 
For the duration of the experiment PaOz 
(Table 8) showed a marked and sustained 
decrease in group 1 (oleic acid only). The 
decrease in PaO, was significantly less 
marked in group 2 (steroid treated ani- 
mals). There was no change in group 3 and 
4 animals. 
In group 1 animals chest roentgenograms 
taken at 3 hr showed diffuse infiltration in 
both lung fields (Fig. 1). These changes 
were either very mild or absent in the 
steroid treated group 2 animals (Fig. 2). 
Chest roentgenograms were normal in 
group 3 and 4 animals. 
Grossly, the lungs in group 1 animals 
were markedly congested with focal areas 
of hemorrhage (Fig. 3). The steroid treated 
animals (group 2) showed some passive 
congestion but to a much lesser degree than 
in the untreated animals (Fig, 4). Histo- 
logically, the nonsteroid treated animals 
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FiQ. 4. Lung from treated animal (group 2) shows much less congec 3tion. 
(group 1) showed marked edema and con- 
gestion with focal areas of hemorrhage and 
inflammation (Fig. 5). The steroid treated 
animals (group 2) showed mild congestion 
and focal mild edema (Fig. 6). The lungs 
in group 3 and 4 animals were normal 
grossly and histologically. Brain and kid- 
ney sections were normal grossly and histo- 
logically in all groups. 
DISCUSSION 
Peltier has suggested the following course 
of events in the pathogenesis of fat emboli: 
emboli of neutral fat lodge in the pul- 
monary arterioles and capillaries ; lung 
lipase hydrolyzes the neutral fat with the 
release of free fatty acids; the free fatty 
acids which are quite toxic cause local in- 
flammation, congestion, and edema, which 
is responsible for the hypoxia always 
present in clinical fat embolism [14]. 
The use of corticosteroids in the treat- 
ment of respiratory distress associated with 
fat embolism was proposed by Ashbaugh 
and Petty in 1966 131. They felt that ste- 
roids might inhibit the local pulmonary in- 
flammatory reaction, improve local blood 
flow and decrease the respiratory distress 
associated with clinical fat embolism. Re- 
cently Fischer et al. reported using large 
doses of corticosteroids in 13 patients with 
respiratory distress syndrome associated 
with fat emboli [9]. They noted that al- 
though PaO, improved soon after the ad- 
ministration of steroids, compliance did not 
improve until up to 72 hr later. They pro- 
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Fig. 6. Photomicrograph of lung tissue from untreated animal (group 1). There is marked 
edema congestion and leucocytic infiltrate. Hematoxylin and eosin. Original magnificat.ion 
x200. 
posed that platelets became adherent to fat 
particles that lodge in the lung vasculature 
and that serotonin and other amines are re- 
leased from the platelets causing pul- 
monary arterial spasm and abnormal ven- 
tilation-perfusion ratios. They suggested 
that steroids counteract the affect of these 
amines and improve the ventilation-perfu- 
sion ratio and improve PaOz. However, it 
is not until the edema fluid and cellular ex- 
udates are resorbed (over a period of a few 
days) that compliance returns to normal. 
This mechanism has also been advocated 
by Moritz et at. who have shown that 
reserpine pretreatment to deplete platelet 
(and other) stores of serotonin and other 
humoral agents results in a less severe re- 
sponse to experimental fat embolism [13]. 
Wertzberger and Peltier [21] showed a 
decrease in the mortality of rats undergoing 
experimental fat embolization when treated 
with large doses of steroids. They proposed 
that the steroids were beneficial for their 
anti-inflammatory properties and their 
ability to modify tissue response to injury 
in conditions associated with capillary 
permeability. 
The period of time between the lodgment 
of neutral fat particles in the lung and the 
release of sufficient free fatty acids to cause 
the inflammatory changes necessary to re- 
sult in respiratory symptoms may represent 
the symptom free interval seen between the 
external trauma and the respiratory dis- 
tress associated with fat embolism [14]. 
The animal model used in this study avoids 
this interval by the direct administration 
of a free fatty acid. Oleic acid is the most 
abundant unsaturated free fatty acid in the 
bones and soft tissues [ 14, 161. A number 
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Fig. 6. Photomicrograph of lung tissue from animal treated with corticosteroids (group a. 
There is minimal edema and cellular infiltrate 
x200. 
of investigators have studied this particular 
model of pulmonary fat embolism and 
found that it results in a pathologic and 
clinical picture entirely similar to that seen 
in humans with respiratory insufficiency 
due to fat embolism (i.e., decreased PaO,, 
roentgenographic changes, congestion, 
edema, and hemorrhage in the lung) [2, 4, 
6, 121. 
The diagnosis of clinical fat embolism is 
often difficult and the various diagnostic 
techniques utilized are not entirely satis- 
factory [S, 11, 15, 19, 22, 231. PaO, reliably 
reflects the severity of respiratory distress 
and is of great value in following the 
progress of patients with pulmonary fat 
embolism [9,22, 231. Chest roentgenograms 
are less reliable but generally provide some 
measure of the severity of pulmonary fat 
Hematoxylin and eosin. Original magnification 
embolization and are a good means of fol- 
lowing patients’ clinical progress [l, 8, 9, 
22, 231. Pulmonary artery pressure has 
been reported to be elevated in experi- 
mental pulmonary fat embolism [4] but 
has not been adequately investigated 
clinically. 
In this study animals treated with oleic 
acid showed a picture similar to the respi- 
ratory distress in patients with pulmonary 
fat embolism. There was a marked decrease 
in PaO?, roentgenographic changes com- 
patible with fat embolism were observed 
and inflammation, edema, congestion, and 
hemorrhage were present in the pulmonary 
parenchyma. 
The animals treated with steroids showed 
significantly less marked changes in all of 
the above. The PaO, decreased less, the 
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roentgenograms showed mild or no changes, 
and tissue changes were less marked both 
grossly and histologically. These results 
suggest that massive corticosteroid therapy 
may be a valuable adjunct to ventilatory 
support in the treatment of the respiratory 
distress associated with fat emboli and sup- 
port the clinical observations of the bene- 
ficial effect of corticosteroids. 
SUMMARY 
Adult mongrel dogs were given intra- 
venous oleic acid in an experimental model 
of pulmonary fat embolism. The changes 
in PaOz, chest roentgenograms, and pul- 
monary tissues were less marked when high 
doses of corticosteroids were administered. 
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